Medical Xpress

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new ...
Morningstar

U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic ...

U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic Lymphoma -- Breakthrough ...
News Medical on MSN

FDA label update expands CAR T access for primary CNS lymphoma

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...
Hosted on MSN

Parents Watch 11-Year-Old Son 'Slowly Fade Away' After Rare Chemo Complication Steals His Ability to Speak and Move (Exclusive)

River Brennan couldn't wait to start middle school, but after his lymphoma diagnosis, doctors said he would miss the entire year River Brennan was diagnosed with T-cell lymphoblastic lymphoma the ...
Medscape

FDA Updates Axi-Cel Safety Label for Large B-Cell Lymphoma

The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...

Metabolon's Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...
Medical Xpress

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Leukemia is a common term used to refer to a form of blood cancer. However, there are different types of leukemia depending on the cell type involved. One unique form is myeloid/natural killer (NK) ...